CDKN3 Antibody
-
中文名稱：CDKN3兔多克隆抗體
-
貨號：CSB-PA005096KA01HU
-
規(guī)格：￥2640
-
圖片：
-
Western blot analysis of extracts of mouse heart cell line, using CDKN3 antibody.
-
-
其他：
產(chǎn)品詳情
-
Uniprot No.：
-
基因名：CDKN3
-
別名：CDI1 antibody; Cdk associated protein phosphatase antibody; CDK2 associated dual specificity phosphatase antibody; CDK2-associated dual-specificity phosphatase antibody; CDKN3 antibody; CDKN3_HUMAN antibody; CIP2 antibody; Cyclin dependent kinase inhibitor 3 antibody; Cyclin dependent kinase interacting protein 2 antibody; Cyclin dependent kinase interactor 1 antibody; Cyclin-dependent kinase inhibitor 3 antibody; Cyclin-dependent kinase interactor 1 antibody; Cyclin-dependent kinase-interacting protein 2 antibody; FLJ25787 antibody; KAP antibody; KAP1 antibody; Kinase associated phosphatase antibody; Kinase-associated phosphatase antibody; MGC70625 antibody; OTTHUMP00000178991 antibody
-
宿主：Rabbit
-
反應種屬：Human,Mouse,Rat
-
免疫原：Recombinant protein of Human CDKN3
-
免疫原種屬：Homo sapiens (Human)
-
抗體亞型：IgG
-
純化方式：Affinity purification
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Store at -20oC or -80oC. Avoid freeze / thaw cycles. Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
-
產(chǎn)品提供形式：Liquid
-
應用范圍：ELISA,WB,IHC
-
推薦稀釋比：
Application Recommended Dilution WB 1:500-1:2000 IHC 1:50-1:200 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產(chǎn)品評價
相關(guān)產(chǎn)品
靶點詳情
-
功能：May play a role in cell cycle regulation. Dual specificity phosphatase active toward substrates containing either phosphotyrosine or phosphoserine residues. Dephosphorylates CDK2 at 'Thr-160' in a cyclin-dependent manner.
-
基因功能參考文獻：
- Results demonstrate that upregulation of p27 is involved in the knockdown of CDKN3-induced decrease in cell proliferation, increase in cell cycle arrest and apoptosis, decrease in invasion, and increase in radiosensitivity. PMID: 28109073
- the mechanism of CDKN3 overexpression in human cancer PMID: 28504190
- CDKN3 is frequently upregulated in gastric cancer tissues and cell lines and is related to advanced clinical stage, recurrence, and poor clinical outcome in gastric cancer. The functional data strongly suggest that CDKN3 behaves as an oncogene in gastric cancer, and downregulation of CDKN3 could inhibit gastric cancer cell proliferation, migration, and invasion, and induce cell cycle arrest and apoptosis. PMID: 27983933
- CDKN3 may act as a tumor suppressor in liver tissues by modulation of the cell survival signal transduction, monitoring carcinogenesis and elimination of abnormal cells. PMID: 27314282
- These results suggest that CDKN3 acts as an oncogene during breast cancer progression. The in vitro silencing of CDKN3 promoted apoptosis, induced G1 phase cell cycle arrest and inhibited cell migration. PMID: 27314680
- Knockdown of Cdkn3 stabilizes Mps1 at centrosomes. PMID: 26586430
- CDKN3 mRNA may be a good survival biomarker and potential therapeutic target in cervical cancer PMID: 26372210
- CDKN3 overexpression in lung adenocarcinoma is not attributed to alternative splicing or mutation but is likely due to increased mitotic activity, arguing against CDKN3 as a tumour suppressor PMID: 26554648
- CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer cells. PMID: 26191143
- These results highlight the importance of CDKN3 in Bcr-Abl-mediated leukemogenesis. PMID: 25360622
- High CDKN3 expression is associated with colorectal cancer. PMID: 25735390
- these data identify KAP as a major regulator of cell division via interactions with numerous target proteins. aberrant splicing or miR-26a decreases KAP expression to promote glioblastoma growth and invasion. PMID: 24704824
- CDKN3 may play an important role in the development and proliferation of epithelial ovarian cancer PMID: 24573179
- KAP is overexpressed in alcohol-related hepatocellular carcinoma. PMID: 23292002
- RelB activation is key for promoting multiple myeloma cell survival through the upregulation of anti-apoptotic proteins, in particular, CIAP2. PMID: 23555623
- CDKN3 controls mitosis through the CDC2 signaling axis. PMID: 23775190
- High CDKN3 expression is associated with cervical cancer. PMID: 23405241
- cyclin-dependent kinase-associated protein phosphatase expression was associated with poorly differentiated Renal cell carcinoma PMID: 21396835
- These results suggest that CDKN3 acts as an oncogene in human hepatocellular carcinoma and antagonism of CDKN3 may be of interest for the treatment of HCC. PMID: 22390936
- analysis of CDKN3 cell cycle networks and the molecular mechanism of non-malignancy associated hepatitis/cirrhosis and HCC transformation PMID: 21535270
- Identification of a KAP domain that interacts with cyclin-dependent kinase 2. PMID: 12745075
- In choline-deficient neuroblastoma cells, the promoter of the cyclin-dependent kinase inhibitor 3 gene (CDKN3) was hypomethylated. This was associated with increased expression of CDKN3 gene product kinase-associated phosphatase (KAP) PMID: 15147518
- Pax3 represses transcription through a novel mechanism involving competition between corepressor KAP1 and the heterochromatin-binding protein HP1gamma PMID: 16945326
- the reduction of KAP1 levels promotes p53-dependent p21 induction and inhibits cell proliferation in actinomycin D-treated cells. PMID: 17056014
顯示更多
收起更多
-
相關(guān)疾病：Hepatocellular carcinoma (HCC)
-
亞細胞定位：Cytoplasm, perinuclear region.
-
蛋白家族：Protein-tyrosine phosphatase family
-
數(shù)據(jù)庫鏈接：
Most popular with customers
-
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-
